OBJECTIVES: This study evaluated the efficacy of catheter-based transcoronary myocardial hypothermia (CTMH) in pigs with acute myocardial ischemia. BACKGROUND: Although it has been suggested that hypothermia therapy can attenuate myocardial necrosis, few applications have been accepted for clinical use. METHODS: This study comprises 2 substudies. In both studies, pigs underwent 60 min of coronary occlusion and 180 min of reperfusion. In study 1, after 15 min of coronary occlusion with an over-the-wire-type balloon (OTWB), pigs in the hypothermia group (H) (n = 13) were directly infused with 4 degrees C saline into the coronary artery through the OTWB wire lumen (2.5 ml/min) for 60 min. Pigs in the normothermia group (N) (n = 15) received the same amount of 36.5 degrees C saline. In study 2, pigs in the hypothermia-reperfusion group (HR) (n = 5) were infused with 4 degrees C saline through the infusion catheter (8 ml/min) for 30 min with a later start (60 min after coronary occlusion), whereas simple reperfusion was used for the reperfusion group (R) (n = 6). RESULTS: Catheter-based transcoronary myocardial hypothermia was successful in both studies. In study 1, CTMH significantly decreased ventricular arrhythmia and the ratio of necrosis to ischemic risk area (H: 9 +/- 2%; N: 36 +/- 4%; p < 0.0001) with a significant reduction of enzyme leaks. In study 2, CTMH tended to reduce the ratio of necrosis (HR: 33 +/- 2%; R: 45 +/- 5%; p = 0.08). In both studies, CTMH significantly suppressed the increase of 8-iso-prostaglandin F(2alpha) while preserving the coronary flow reserve. CONCLUSIONS: Catheter-based transcoronary myocardial hypothermia reduced myocardial necrosis while preserving coronary flow reserve, due, in part, to attenuation of oxidative stress.
OBJECTIVES: This study evaluated the efficacy of catheter-based transcoronary myocardial hypothermia (CTMH) in pigs with acute myocardial ischemia. BACKGROUND: Although it has been suggested that hypothermia therapy can attenuate myocardial necrosis, few applications have been accepted for clinical use. METHODS: This study comprises 2 substudies. In both studies, pigs underwent 60 min of coronary occlusion and 180 min of reperfusion. In study 1, after 15 min of coronary occlusion with an over-the-wire-type balloon (OTWB), pigs in the hypothermia group (H) (n = 13) were directly infused with 4 degrees C saline into the coronary artery through the OTWB wire lumen (2.5 ml/min) for 60 min. Pigs in the normothermia group (N) (n = 15) received the same amount of 36.5 degrees C saline. In study 2, pigs in the hypothermia-reperfusion group (HR) (n = 5) were infused with 4 degrees C saline through the infusion catheter (8 ml/min) for 30 min with a later start (60 min after coronary occlusion), whereas simple reperfusion was used for the reperfusion group (R) (n = 6). RESULTS: Catheter-based transcoronary myocardial hypothermia was successful in both studies. In study 1, CTMH significantly decreased ventricular arrhythmia and the ratio of necrosis to ischemic risk area (H: 9 +/- 2%; N: 36 +/- 4%; p < 0.0001) with a significant reduction of enzyme leaks. In study 2, CTMH tended to reduce the ratio of necrosis (HR: 33 +/- 2%; R: 45 +/- 5%; p = 0.08). In both studies, CTMH significantly suppressed the increase of 8-iso-prostaglandin F(2alpha) while preserving the coronary flow reserve. CONCLUSIONS: Catheter-based transcoronary myocardial hypothermia reduced myocardial necrosis while preserving coronary flow reserve, due, in part, to attenuation of oxidative stress.
Authors: Renaud Tissier; Mourad Chenoune; Bijan Ghaleh; Michael V Cohen; James M Downey; Alain Berdeaux Journal: Cardiovasc Res Date: 2010-07-08 Impact factor: 10.787
Authors: Luuk C Otterspoor; Lokien X van Nunen; Tilaï T Rosalina; Marcel Van't Veer; Sjoerd Van Tuijl; Marco Stijnen; Marcel Cm Rutten; Frans N van de Vosse; Nico Hj Pijls Journal: Am J Transl Res Date: 2017-02-15 Impact factor: 4.060
Authors: Hirotsugu Hamamoto; Hiroaki Sakamoto; Bradley G Leshnower; Landi M Parish; Shinya Kanemoto; Robin Hinmon; Theodore Plappert; Shinji Miyamoto; Martin G St John-Sutton; Joseph H Gorman; Robert C Gorman Journal: Ann Thorac Surg Date: 2009-01 Impact factor: 4.330
Authors: Shinya Kanemoto; Muneaki Matsubara; Mio Noma; Bradley G Leshnower; Landi M Parish; Benjamin M Jackson; Robin Hinmon; Hirotsugu Hamamoto; Joseph H Gorman; Robert C Gorman Journal: Ann Thorac Surg Date: 2009-01 Impact factor: 4.330
Authors: Henry G Riter; Leonard A Brooks; Andrew M Pretorius; Laynez W Ackermann; Richard E Kerber Journal: Resuscitation Date: 2009-02-26 Impact factor: 5.262
Authors: Christoph Testori; Fritz Sterz; Wilhelm Behringer; Alexander Spiel; Christa Firbas; Bernd Jilma Journal: Crit Care Date: 2011-10-22 Impact factor: 9.097
Authors: Mohamed El Farissi; Thomas P Mast; Mileen R D van de Kar; Daimy M M Dillen; Jesse P A Demandt; Fabienne E Vervaat; Rob Eerdekens; Simon A G Dello; Danielle C Keulards; Jo M Zelis; Marcel van 't Veer; Frederik M Zimmermann; Nico H J Pijls; Luuk C Otterspoor Journal: J Clin Med Date: 2022-02-18 Impact factor: 4.241
Authors: Christoph Testori; Fritz Sterz; Georg Delle-Karth; Reinhard Malzer; Michael Holzer; Peter Stratil; Mathias Stöckl; Christoph Weiser; Raphael van Tulder; Clemens Gangl; Dieter Sebald; Andreas Zajicek; Angelika Buchinger; Irene Lang Journal: Heart Date: 2013-09-24 Impact factor: 5.994